“borderline significant”

Interventions Percutaneous coronary intervention (PCI) demonstrated a borderline significant association with recurrence ( p = 0.050).

Race interaction: borderline significant (overall p = 0.05).

22 Two-way ANOVA showed a borderline significant effect of genotype on winning (F = 5.48, df = 2, 136, P = .05) but no significant effect of sex or sex by genotype interaction.

Only MEL was borderline significant ( X 2 = 3.75, p = 0.05), with children from highly educated mothers (mean score 0.49) achieving higher scores than the other children (mean score −0.07), although the posthoc comparison was not significant after Bonferroni correction (0.50, p = 0.06).

A borderline significant interaction (p = 0.05) was observed for one outcome: concordance between stated decision and action taken, where encounters with female clinician/male patient showed increased concordance in the decision aid arm compared to control (8% more concordant encounters).

Being consistently inactive was associated with higher odds of having overweight/obesity according to all outcomes (borderline significant for WHtR ≥ 0.6 (p = 0.05)) compared to being consistently active.

Shown in Figure 2 , meta‐analysis of dichotomous cerebrovascular reactivity revealed a borderline significant association between an impaired cerebrovascular reactivity and an increased prevalence of cSVD (dichotomous predictor pooled OR, 2.26 [95% CI, 0.99–5.14], P =0.05).

Only a borderline significant association was observed in the pooled analysis for ins/ins genotype ( P = 0.05).

Furthermore, administration of activated charcoal after PQ consumption showed a borderline significant positive association with survival (HR: 3.15, 95% CI: 0.99–10.08, p = 0.05) ( Table 3 ).

The OR at NPAR ≥ 0.92 remains at the borderline significant level ( P = 0.050), but the overall analysis does not support the existence of a threshold effect.

This association was borderline significant after adjustment (adjusted OR: 3.73; 95% CI: 0.97–14.35; p = 0.05).

A borderline significant difference for elevated arterial hypertension rates was seen in BAC-positive patients (35% vs. 27%, p = 0.05).

For hamstrings, the pooled effect was smaller and borderline significant (SMD = 1.48 [− 0.01, 2.97], Z = 1.94, p = 0.05; I 2 = 81%), indicating variability across studies.

In untreated cells, limited or no HIV gag-p24 protein was detected across all cell pellets (average 0.019 ± 0.009 pg/mL, assuming a value of 0.005 pg/mL for all samples with gag-p24 below the LOD), while anti-CD3/CD28 induced an average 0.138 ± 0.070 pg/mL of viral protein, or a borderline significant 7.6-fold increase over no-drug control ( P = 0.05; Fig. 4B ).

Acute lower respiratory symptoms were associated with lower CCL17 [estimate: 0.6 pg/ml, (95% CI: 0.5–0.8), p < 0.001] and a borderline significant lower level of CCL20 [estimate: 0.5 pg/ml (95% CI: 0.2–1.0), p = 0.05] ( Table 4 ).

Smedman and Vessby [ 15 ] reported a borderline significant (P = 0.05) reduction in the percent body fat of normal weight subjects fed CLA (4.2 g/d for 12 weeks) as compared to the placebo group.

Moreover, the presence of chocolate ingredient had a borderline significant effect on AFB1 (p = 0.05) and a significant effect on OTA (p = 0.002), with higher percentages observed in SKUs containing chocolate.

However, there was a borderline significant difference (p = 0.05) for pancreatic insufficiency: all patients included in the rapid group were pancreatic insufficient, while 15 of the 18 patients in the slow progression group were pancreatic insufficient.

Laboratory findings showed that WBC values were slightly higher in the fibrotic group ( Table 2 ), but the difference was borderline significant (p=0.05); there was no significant difference between the groups in CRP and LDH values.

The second measure of self-reported anxiety (SCARED) also revealed a borderline significant change over time [ F (2, 12) = 3.41, p = 0.050].

A borderline significant negative association with rheumatologic diseases was also observed (aOR 0.77 [95% CI 0.59–1.00]; p = 0.05).

The HRs for the continuous PRS were not significantly different between the BCFR and kConFab study cohorts (p=0.13) for study*PRS interaction, but were borderline significant for the upper vs. lower quintile (P=0.05), nor did the HR vary significantly as a function of age at baseline (p=0.88 and p=0.71 for the two cohorts, respectively).

In the unadjusted comparison of outcomes between the IMN and ORIF pairs, there were no statistically significant differences, although the greater prevalence of revisions in the ORIF cohort was borderline significant ( p = 0.05) (Table 3 ).

In the multivariate analysis, there was a borderline significant risk reduction of 20% with increased activity (aHR moderate 0.80, 95% CI 0.63-1.00, p=0.05 and aHR high 0.80, 95% CI 0.64-1.01, p=0.06).

There was also a borderline significant difference by residence, with higher HBV seroprevalence observed among urban dwellers compared to rural participants (14.9% vs. 7.3%; p = 0.050).